Name: EnterNext welcomes Crossject on Alternext Paris
Uploaded: 2014-02-20T10:00:00+0100
Description: Patrick Alexandre, Chairman and Chief Executive Officer of Crossject rings the closing bell. Crossject specializes in manufacturing and marketing needleless drug self-injection. The group provides Zeneo, a prefilled and single-use device that can be used for intradermal, subcutaneous and intramuscular injections.

Search Contact

This page is available in multiple languages

Select Language

Back

20/02/2014

Patrick Alexandre, Chairman and Chief Executive Officer of Crossject rings the closing bell.

Crossject specializes in manufacturing and marketing needleless drug self-injection. The group provides Zeneo, a prefilled and single-use device that can be used for intradermal, subcutaneous and intramuscular injections.